Klick Health has introduced Klick Comment Moderator+AI (KCM+AI), setting a new standard in social media comment moderation for the life sciences sector. The innovative platform, powered by Microsoft Azure AI and Klick’s proprietary model trained on nearly 400,000 historical comments, significantly enhances pharmacovigilance (PV) detection and reporting capabilities. KCM+AI aims to streamline community management processes, providing 24/7 monitoring and automatic comment-holding.
Enhanced pharmacovigilance capabilities with AI integration
Klick Health’s KCM+AI leverages advanced artificial intelligence to bolster pharmacovigilance efforts within the life sciences industry. By analyzing social media comments in real time, the platform detects adverse events and product complaints with over 95 percent accuracy. This proactive approach ensures timely identification and reporting of potential issues, empowering brands to maintain compliance and safeguard their online reputation.
With the introduction of KCM+AI, Klick Health has redefined social media community management for pharmaceutical brands. The platform’s AI-driven automation streamlines moderation processes, automatically flagging and holding comments for review by Klick’s community managers. Comments requiring responses are promptly routed to the agency’s Science & Regulatory team, ensuring swift and appropriate action.
Client testimonials reflect excitement and confidence in AI advancements
Acorda Therapeutics’ Executive Director, Digital Strategy & Development Rich Muser expressed enthusiasm for KCM+AI’s potential to enhance social media engagement safety and compliance. Likewise, Acorda’s Vice President of Digital Strategy and Innovation Michael Russo praised the platform’s advanced AI capabilities, highlighting its promise to revolutionize pharmacovigilance practices within the pharmaceutical industry.
Brad Einarsen, Klick Health’s Senior Vice President of Strategic Futures, views KCM+AI as a digital assistant that fortifies brand protection against pharmacovigilance issues. By leveraging AI-driven moderation, the platform enables community managers to focus on strategic initiatives and high-level engagement, thereby maximizing efficiency and productivity.
Continued commitment to innovation and excellence
Today’s launch of KCM+AI represents Klick Health’s ongoing dedication to leveraging AI and machine learning to drive positive outcomes for clients. The company’s recent initiatives, including the $1 million Klick Prize for AI innovation and the unveiling of LOVENet and Genome Perspective, underscore its commitment to pushing boundaries and delivering cutting-edge solutions in the life sciences space.
Klick Health stands as the world’s largest independent commercialization partner for life sciences, specializing in developing, launching, and supporting brands to achieve their full potential. With a comprehensive suite of services spanning marketing, advertising, medical affairs, and omnichannel enablement, Klick Health is recognized for its deep medical expertise, data-driven decision sciences capabilities, and award-winning creativity.
In 2023, Klick Health earned numerous accolades, including Clio Health Independent Agency of the Year and Cannes Lions’ recognition as a top healthcare agency and independent agency. The company’s commitment to excellence is reflected in its consistent recognition as a Best Managed Company, Great Place to Work, and FORTUNE Best Workplace in Advertising.
Klick Health’s introduction of KCM+AI marks a significant milestone in the evolution of social media moderation within the life sciences industry. By harnessing the power of artificial intelligence, the platform delivers unparalleled pharmacovigilance capabilities, streamlining processes and empowering brands to navigate the complexities of online engagement with confidence. As Klick Health continues to innovate and push boundaries, it reaffirms its position as a leader in driving positive outcomes for clients and advancing the frontiers of healthcare marketing and communications.
